Related Experiment Video
Updated: May 22, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Third-generation analogues of Guttiferone A
David Hozain1, Kevin Cottet1, Yann Fromentin1
1UMR CNRS 8038 CiTCoM, PNAS Team, Université Paris Cité, 75006 Paris, France.
Third-generation guttiferone A derivatives show enhanced activity against Plasmodium falciparum and Trypanosoma brucei. Monodioxolane substitution in compound 3 significantly improved selectivity and potency.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Organic Synthesis
Background:
- Guttiferone A derivatives are investigated for antiparasitic activity.
- Developing new treatments against Plasmodium falciparum and Trypanosoma brucei is crucial.
Purpose of the Study:
- To synthesize and evaluate third-generation guttiferone A derivatives.
- To enhance bioactivity and selectivity against Plasmodium falciparum and Trypanosoma brucei.
Main Methods:
- Optimized synthetic route to prepare dioxolane derivatives of 3,16-oxyguttiferone A.
- Biological evaluation of synthesized compounds against parasitic strains.
- Determination of selectivity index (SI) for antiparasitic activity.
Main Results:
- Compound 3 (14-monodioxolane-3,16-oxyguttiferone A) exhibited the highest efficacy.
- Compound 3 showed SI of 457.1 against Trypanosoma brucei brucei and 57.1 against P. falciparum.
- Compound 4 (13,14-bisdioxolane-3,16-oxyguttiferone A) demonstrated significant activity with SI of 143.8 against T. brucei.
Conclusions:
- Targeted structural modifications, specifically monodioxolane substitution, can improve guttiferone A derivatives' pharmacological profile.
- These novel derivatives show promise as lead compounds for developing new antiparasitic agents.
- Further research into these compounds could lead to effective treatments for neglected tropical diseases.
More Related Videos
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
09:04A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Constipation-Predominant IBS
Antipsychotic Drugs: Typical and Atypical Agents
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents